Quanterix Co. (NASDAQ:QTRX) Shares Acquired by Clearbridge Investments LLC

Clearbridge Investments LLC grew its stake in Quanterix Co. (NASDAQ:QTRXGet Rating) by 0.3% in the second quarter, Holdings Channel reports. The fund owned 486,160 shares of the company’s stock after purchasing an additional 1,475 shares during the period. Clearbridge Investments LLC’s holdings in Quanterix were worth $7,871,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also modified their holdings of QTRX. RTW Investments LP increased its stake in shares of Quanterix by 81.9% in the 1st quarter. RTW Investments LP now owns 1,248,517 shares of the company’s stock worth $36,444,000 after acquiring an additional 562,047 shares during the last quarter. Invesco Ltd. grew its holdings in shares of Quanterix by 73.3% during the 1st quarter. Invesco Ltd. now owns 1,097,126 shares of the company’s stock worth $32,026,000 after purchasing an additional 464,139 shares during the period. Granahan Investment Management LLC grew its holdings in shares of Quanterix by 56.1% during the 1st quarter. Granahan Investment Management LLC now owns 1,152,982 shares of the company’s stock worth $33,656,000 after purchasing an additional 414,442 shares during the period. Assenagon Asset Management S.A. grew its holdings in shares of Quanterix by 302.8% during the 2nd quarter. Assenagon Asset Management S.A. now owns 163,800 shares of the company’s stock worth $2,652,000 after purchasing an additional 123,139 shares during the period. Finally, Tikvah Management LLC grew its holdings in shares of Quanterix by 26.2% during the 1st quarter. Tikvah Management LLC now owns 436,119 shares of the company’s stock worth $12,730,000 after purchasing an additional 90,600 shares during the period. 91.85% of the stock is owned by institutional investors and hedge funds.

Quanterix Stock Down 2.1 %

QTRX stock opened at $11.79 on Friday. The business’s 50-day moving average is $10.25 and its two-hundred day moving average is $13.30. Quanterix Co. has a 1 year low of $6.31 and a 1 year high of $44.86.

Analyst Ratings Changes

A number of equities analysts recently commented on the company. Cowen cut Quanterix from an “outperform” rating to a “market perform” rating and lowered their target price for the company from $38.00 to $18.00 in a report on Tuesday, August 9th. The Goldman Sachs Group lowered their target price on Quanterix from $15.00 to $13.00 and set a “neutral” rating for the company in a report on Thursday, November 10th. SVB Leerink raised their target price on Quanterix from $12.00 to $15.00 and gave the company a “market perform” rating in a report on Wednesday, November 9th. Cowen cut Quanterix from an “outperform” rating to a “market perform” rating in a report on Tuesday, August 9th. Finally, Canaccord Genuity Group cut Quanterix from a “buy” rating to a “hold” rating and lowered their target price for the company from $40.00 to $12.00 in a report on Monday, August 15th. Six analysts have rated the stock with a hold rating and one has given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $26.00.

About Quanterix

(Get Rating)

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids.

Featured Stories

Want to see what other hedge funds are holding QTRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Quanterix Co. (NASDAQ:QTRXGet Rating).

Institutional Ownership by Quarter for Quanterix (NASDAQ:QTRX)

Receive News & Ratings for Quanterix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quanterix and related companies with MarketBeat.com's FREE daily email newsletter.